Hyperoxemia and excess oxygen use in early acute respiratory distress syndrome: insights from the LUNG SAFE study - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Critical Care Année : 2020

Hyperoxemia and excess oxygen use in early acute respiratory distress syndrome: insights from the LUNG SAFE study

Emanuele Rezoagli
  • Fonction : Auteur
Tài Pham
Marcello Schmidt
  • Fonction : Auteur
Bairbre Mcnicholas
  • Fonction : Auteur
Alessandro Protti
  • Fonction : Auteur
Rakshit Panwar
  • Fonction : Auteur
Giacomo Bellani
  • Fonction : Auteur
Eddy Fan
  • Fonction : Auteur
Frank van Haren
  • Fonction : Auteur
Laurent Brochard
  • Fonction : Auteur
John Laffey

Résumé

Abstract Background Concerns exist regarding the prevalence and impact of unnecessary oxygen use in patients with acute respiratory distress syndrome (ARDS). We examined this issue in patients with ARDS enrolled in the L arge observational study to UN derstand the Gl obal impact of S evere A cute respiratory F ailur E (LUNG SAFE) study. Methods In this secondary analysis of the LUNG SAFE study, we wished to determine the prevalence and the outcomes associated with hyperoxemia on day 1, sustained hyperoxemia, and excessive oxygen use in patients with early ARDS. Patients who fulfilled criteria of ARDS on day 1 and day 2 of acute hypoxemic respiratory failure were categorized based on the presence of hyperoxemia (PaO 2 > 100 mmHg) on day 1, sustained (i.e., present on day 1 and day 2) hyperoxemia, or excessive oxygen use (FIO 2 ≥ 0.60 during hyperoxemia). Results Of 2005 patients that met the inclusion criteria, 131 (6.5%) were hypoxemic (PaO 2 < 55 mmHg), 607 (30%) had hyperoxemia on day 1, and 250 (12%) had sustained hyperoxemia. Excess FIO 2 use occurred in 400 (66%) out of 607 patients with hyperoxemia. Excess FIO 2 use decreased from day 1 to day 2 of ARDS, with most hyperoxemic patients on day 2 receiving relatively low FIO 2 . Multivariate analyses found no independent relationship between day 1 hyperoxemia, sustained hyperoxemia, or excess FIO 2 use and adverse clinical outcomes. Mortality was 42% in patients with excess FIO 2 use, compared to 39% in a propensity-matched sample of normoxemic (PaO 2 55–100 mmHg) patients ( P = 0.47). Conclusions Hyperoxemia and excess oxygen use are both prevalent in early ARDS but are most often non-sustained. No relationship was found between hyperoxemia or excessive oxygen use and patient outcome in this cohort. Trial registration LUNG-SAFE is registered with ClinicalTrials.gov, NCT02010073
Fichier principal
Vignette du fichier
PDF Datastream-1.pdf (1.47 Mo) Télécharger le fichier
Origine : Publication financée par une institution

Dates et versions

hal-03715270 , version 1 (22-11-2022)

Identifiants

Citer

Fabiana Madotto, Emanuele Rezoagli, Tài Pham, Marcello Schmidt, Bairbre Mcnicholas, et al.. Hyperoxemia and excess oxygen use in early acute respiratory distress syndrome: insights from the LUNG SAFE study. Critical Care, 2020, 24 (1), pp.125. ⟨10.1186/s13054-020-2826-6⟩. ⟨hal-03715270⟩
7 Consultations
18 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More